Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$57.89

-3.85 (-6.24%)

, SMMT

Summit Therapeutics

$11.92

-1.45 (-10.85%)

10:42
10/10/16
10/10
10:42
10/10/16
10:42

Sarepta and Summit Therapeutics to hold a joint conference call

Sarepta and Summit Therapeutics discuss their exclusive license and collaboration agreement granding Sarepta rights in Europe, as well as Turkey and the Commonwealth of Independent States to Summit's utrophin modulator pipeline, including its lead clinical candidate, Ezutromid for treating Duchenne Muscular Dystrophy in a joint conference call to be held on October 10 at 12 pm.

SRPT

Sarepta

$57.89

-3.85 (-6.24%)

SMMT

Summit Therapeutics

$11.92

-1.45 (-10.85%)

  • 11

    Oct

  • 06

    Nov

SRPT Sarepta
$57.89

-3.85 (-6.24%)

09/28/16
JMPS
09/28/16
NO CHANGE
JMPS
Street underestimating price of Sarepta drug, says JMP Securities
JMP Securities analyst Liisa Bayko expects the price of Sarepta's Exondys 51 drug will be above the company's projected annual net price of $300,000. She thinks that the price will come in "closer to $538,000 per year on a gross basis, $457,000 net of discounts and compliance." The analyst raised her price target on the shares to $90 from $60 and keeps an Outperform rating on the stock.
10/04/16
PIPR
10/04/16
NO CHANGE
Target $68
PIPR
Overweight
Piper Jaffray ups Sarepta target to $68 on Summit deal
Piper Jaffray analyst Edward Tenthoff raised his price target for Sarepta Therapeutics (SRPT) to $68 from $64 after the company licensed Summit Therapeutics' (SMMT) ezutromid to treat Duchenne Muscular Dystrophy in Europe, Turkey and the Commonwealth of Independent States. The deal is a smart way for Sarepta to capitalize on its lead in DMD with the recent FDA approval of Exondys51, Tenthoff tells investors in an intraday research note. His new price target of $68 reflects the value of ezutromid. Tenthoff reiterates an Overweight rating on Sarepta. The stock is up 1% to $61.61 in late morning trading. Summit is up 94%, or $8.17, to $16.82.
10/05/16
ADAM
10/05/16
NO CHANGE
Target $28
ADAM
Buy
Summit Therapeutics price target raised to $28 from $14 at Canaccord
Canaccord analyst Arinda Lee raised her price target on Summit Therapeutics (SMMT) to $28 from $14 following the announcement of its collaboration and licensing agreement with Sarepta Therapeutics (SRPT). The deal calls for Sarepta to gain EU commercialization rights to Summit's pipeline of oral utrophin modulators for all patients with Duchenne muscular dystrophy. Lee reiterated her Buy rating Summit Therapeutics shares.
10/07/16
BARD
10/07/16
NO CHANGE
Target $102
BARD
Outperform
Anthem policy does not mean insurer not covering Sarepta drug, says Baird
Baird analyst Brian Skorney noted Anthem (ANTM) has categorized Sarepta (SRPT) Duchenne muscular dystrophy drug Exondys 51 as "not medically necessary" in a new coverage policy, but he cautions this "does not mean that Anthem is not covering the drug." The analyst explains that the policy means prior authorization requirements may be stricter, but he "highly doubts" that eligible patients will be denied coverage. Skorney, who adds that other large insurers appear to have favorable coverage for the drug, keeps an Outperform rating and $102 price target on Sarepta shares.
SMMT Summit Therapeutics
$11.92

-1.45 (-10.85%)

10/04/16
NEED
10/04/16
NO CHANGE
Target $30
NEED
Buy
Summit Therapeutics price target raised to $30 from $22 at Needham
Sarepta Therapeutics (SRPT) and Summit Therapeutics (SMMT) announced this morning that they have entered into an exclusive license and collaboration agreement granting Sarepta rights in Europe, as well as in Turkey and the Commonwealth of Independent States, to Summit's utrophin modulator pipeline, including its lead clinical candidate, ezutromid, for the treatment of Duchenne muscular dystrophy.
10/04/16
JMPS
10/04/16
NO CHANGE
JMPS
Outperform
Summit Therapeutics price target raised to $42 from $24 at JMP Securities

TODAY'S FREE FLY STORIES

MSTX

Mast Therapeutics

$0.14

0.003 (2.22%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Mast Therapeutics to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

MTSI

MACOM

$50.32

-3.52 (-6.54%)

, SBGI

Sinclair Broadcast

$40.35

1.05 (2.67%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
National Association of Broadcasters to hold a conference »

NAB Show 2017 is being…

MTSI

MACOM

$50.32

-3.52 (-6.54%)

SBGI

Sinclair Broadcast

$40.35

1.05 (2.67%)

NXST

Nexstar

$69.90

1 (1.45%)

TRCO

Tribune Media

$36.72

0.17 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 09

    May

  • 22

    May

  • 23

    May

CLLS

Cellectis

$23.83

0.26 (1.10%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Cellectis management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 28

    Apr

  • 03

    May

  • 06

    Jun

RDHL

RedHill Biopharma

$10.29

0.0199 (0.19%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
RedHill Biopharma to host research and development day »

Research &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 03

    May

RXDX

Ignyta

$9.20

0.25 (2.79%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Ignyta holds a conference call »

Management provides a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 06

    Jun

BGG

Briggs & Stratton

$25.14

0.09 (0.36%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Briggs & Stratton management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

  • 10

    May

GTN

Gray Television

$15.05

0.4 (2.73%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Gray Television management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 28

    Apr

  • 03

    May

  • 04

    May

SGM

Stonegate Mortgage

$7.96

-0.0059 (-0.07%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Stonegate Mortgage to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

04:55
04/27/17
04/27
04:55
04/27/17
04:55
General news
Breaking General news story  »

Week of 4/21 EIA Natural…

CMRX

Chimerix

$6.09

-0.01 (-0.16%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Chimerix to hold an investor update webcast »

Chief Medical Officer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

04:55
04/27/17
04/27
04:55
04/27/17
04:55
General news
Pending Home Sales Index to be reported at 10:00 »

March Pending Home Sales…

RGLS

Regulus

$1.55

0.1 (6.90%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Regulus management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Berenberg to hold a conference »

U.K. Corporate Conference…

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
The Food & Drug Law Institute to hold a conference »

Introduction to U.S. Drug…

04:55
04/27/17
04/27
04:55
04/27/17
04:55
General news
Jobless Claims to be reported at 08:30 »

Week of 4/22 Jobless…

04:55
04/27/17
04/27
04:55
04/27/17
04:55
General news
Breaking General news story  »

Week of 4/23 Bloomberg…

04:55
04/27/17
04/27
04:55
04/27/17
04:55
General news
Breaking General news story  »

6-Month Bill Announcement…

04:55
04/27/17
04/27
04:55
04/27/17
04:55
General news
Breaking General news story  »

3-Month Bill Announcement…

04:55
04/27/17
04/27
04:55
04/27/17
04:55
General news
Breaking General news story  »

Week of 4/17 Money Supply…

04:55
04/27/17
04/27
04:55
04/27/17
04:55
General news
Breaking General news story  »

Week of 4/26 Fed Balance…

LGF

Use LGF.A, LGF.B

, AMCX

AMC Networks

$60.25

0.65 (1.09%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
FBN Securities media/cable analyst holds an analyst/industry conference call »

Media. Cable &…

LGF

Use LGF.A, LGF.B

AMCX

AMC Networks

$60.25

0.65 (1.09%)

DISCA

Discovery

$29.39

0.1 (0.34%)

CBS

CBS

$66.91

0.5 (0.75%)

NFLX

Netflix

$150.17

-1.99 (-1.31%)

AMZN

Amazon.com

$909.29

1.67 (0.18%)

VIA.B

Symbol now VIAB

NLSN

Nielsen

$39.41

-0.57 (-1.43%)

SNI

Scripps Networks

$76.49

0.53 (0.70%)

TWX

Time Warner

$100.20

0.16 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 04

    May

  • 04

    May

  • 08

    May

  • 16

    May

  • 16

    May

  • 18

    May

  • 18

    May

  • 23

    May

  • 31

    May

  • 05

    Jun

  • 15

    Jun

MEOH

Methanex

$46.10

0.15 (0.33%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Methanex Corporation to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

04:55
04/27/17
04/27
04:55
04/27/17
04:55
General news
Durable Goods Orders to be reported at 08:30 »

March Durable Goods…

04:55
04/27/17
04/27
04:55
04/27/17
04:55
General news
Durable Goods Orders Ex-transportation to be reported at 08:30 »

March Durable Goods…

WWD

Woodward

$68.05

-0.11 (-0.16%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
Woodward management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 28

    Apr

  • 09

    May

  • 11

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.